CRISPR/Cas as a tool to overcome drug resistance in cancer: From challenge to opportunity
Drug resistance remains a significant challenge in cancer therapy, often resulting in treatment failure, tumor progression, and metastasis. The underlying resistance mechanisms—including genetic mutations, epigenetic alterations, and modifications in drug efflux pathways—are complex and not yet full...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2025-12-01
|
| Серія: | Molecular and Cellular Probes |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S0890850825000453 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|